Literature DB >> 32469794

Sex differences in the associations between blood pressure and anxiety and depression scores in a middle-aged and elderly population: The Irish Longitudinal Study on Ageing (TILDA).

Ying Huang1, Yuhao Su1, Ying Jiang2, Meilan Zhu3.   

Abstract

BACKGROUND: Anxiety and depression are considered risk factors for cardiovascular diseases (CVDs), but their relationship to blood pressure (BP) is still uncertain. Lifestyle factors and age-related comorbidities may confound these relationships. Our study aimed to evaluate the associations between BP and anxiety and depression scores in a population aged ≥49 years.
METHODS: Data on 8504 participants from The Irish Longitudinal Study on Ageing (TILDA) were analyzed for associations between BP and anxiety and depression questionnaire scores, accounting for relevant confounding factors.
RESULTS: Multivariable analyses showed negative associations between systolic BP and anxiety and depression scores, independent of age, body mass index (BMI), marital status, education level, smoking status, alcohol consumption, level of physical activity, self-reported CVDs (≥2) and antihypertensive medication use in men (coefficient=-0.112, P=0.013; coefficient=-0.051, P=0.026) but not in women (coefficient=-0.001, P=0.855; coefficient=-0.005, P=0.556). Diastolic BP was not associated with anxiety or depression scores in either men (coefficient=-0.018, P=0.223; coefficient=-0.001, P=0.924) or women (coefficient=-0.007, P=0.338; coefficient=-0.015, P=0.293) after adjusting for these same confounding factors. After a follow-up of 4 years, lower BP in subjects not using antihypertensive medications was significantly associated with more anxiety and depression events. LIMITATION: Time-varying confounding factors may have interfered with our results.
CONCLUSION: Our results show that systolic BP in a middle-aged and elderly population is negatively associated with anxiety and depression scores in men but not women after adjustment for a range of lifestyle factors. These results contrast with the predisposition of anxious or depressed participants to CVDs in later life when decades of unhealthy lifestyles have persisted.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Blood pressure; Depression; Longitudinal study; Middle-aged and elderly population

Mesh:

Year:  2020        PMID: 32469794     DOI: 10.1016/j.jad.2020.05.133

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Depression and Perceived Stress, but Not Anxiety, are Associated with Elevated Inflammation in an Obese Adult Population.

Authors:  Bin Zou; Chenfang Miao; Jiliang Chen
Journal:  Risk Manag Healthc Policy       Date:  2020-09-09

2.  Anxiety disorders and age-related changes in physiology.

Authors:  Julian Mutz; Thole H Hoppen; Chiara Fabbri; Cathryn M Lewis
Journal:  Br J Psychiatry       Date:  2022-09       Impact factor: 10.671

3.  Increased Levels of Serum Glycosylated Hemoglobin are Associated with Depressive Symptoms in a Population with Cancer (≥49 Years): An Antidepressant-Stratified Analysis.

Authors:  Ying Huang; Yilin Xu; Anwen Liu
Journal:  Clin Interv Aging       Date:  2021-02-02       Impact factor: 4.458

4.  Serum Human Epididymal Protein 4 is Associated with Depressive Symptoms in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Yan Shu; Wei Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-12-30

5.  Increased Blood Lipid Level is Associated with Cancer-Specific Mortality and All-Cause Mortality in Patients with Colorectal Cancer (≥65 Years): A Population-Based Prospective Cohort Study.

Authors:  Yong Yang; Ge Gao; Jun Shi; Jiangnan Zhang
Journal:  Risk Manag Healthc Policy       Date:  2020-07-23

6.  Relationship Between Serum Fibrinogen Level and Depressive Symptoms in an Adult Population with Spinal Cord Injury: A Cross-Sectional Study.

Authors:  Zhiping Xie; Chengcai Li; Zelong Xing; Wu Zhou; Shenke Xie; MeiHua Li; Yujuan Zhou
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-06       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.